rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Polyrizon Ltd. -

PLRZ · Nasdaq

Health CareMedical DevicesNot moving yet

PLRZ stood above a rising 150-day average in 27 of the last 52 weekly readings, and has been out of that trend for the last 12 weeks. It is 22.5% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 12
Industry in uptrend
27% -7 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$265K
Officials’ trades on record
0
Institutions holding
4 (+1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 27 of 52 weeks.

20 Apr – 19 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$256K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months6
Buyers · sellers0 · 4
WhoDidSharesTraded
Oz AdlerDirectorsold3,292at $12.0531 Mar 2026filed 1 Apr 2026
Liron CarmelDirectorsold942at $12.3631 Mar 2026filed 1 Apr 2026
Tomer IzraeliChief Executive Officersold500at $11.8531 Mar 2026filed 1 Apr 2026
Tidhar TurgemanChief Technology Officersold2,917at $10.9030 Mar 2026filed 31 Mar 2026
Tomer IzraeliChief Executive Officersold3,900at $10.9030 Mar 2026filed 31 Mar 2026
Liron CarmelDirectorsold100at $11.0030 Mar 2026filed 31 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders4+1 on the quarter
New · exited4 · 3
Reported value$2.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
MMCAP International Inc. SPCnew · filed 14 Aug 2026199,470$2.5M+199,470
MERCER GLOBAL ADVISORS INCnew · filed 11 Aug 20261,667$21K+1,667
Caitong International Asset Management Co., Ltdnew · filed 5 Aug 202611$138+11
MORGAN STANLEYnew · filed 13 Aug 20263$38+3
31 Dec 2025 – 30 Jun 2026
344Dec 25Mar 26Jun 26

Everyone who traded it

Liron Carmel Company insiderDirector · last 31 Mar 20260 · 2
Oz Adler Company insiderDirector · last 31 Mar 20260 · 1
Tomer Izraeli Company insiderChief Executive Officer · last 31 Mar 20260 · 2
Tidhar Turgeman Company insiderChief Technology Officer · last 30 Mar 20260 · 1

Same industry

RCEL Avita MedicalLeading+100%
HAE HaemoneticsLeading+48%
ATRC AtriCureLeading+47%
HTFL HeartflowLeading+47%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-29.8%
Earnings per share growthFY 2025 · to 31 Dec 2025880%
Share count trendFY 2025 · to 31 Dec 2025-61.7%
Cash and equivalentsFY 2025 · to 31 Dec 2025$1.3M
Free cash flowFY 2025 · to 31 Dec 2025−$4.5M

Analyst forecasts

No analyst forecasts yet.